David Galloway, M.D., Pediatric Gastroenterology, Hepatology & Nutrition, has been appointed to the Clinical Care and Quality Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). Dr. Galloway will serve a three year term from October 2016 - October 2019.
Click here for more about NASPGHAN.
Click here for more about NASPGHAN.
Prescott Atkinson, M.D., Ph.D., Pediatric Allergy, Asthma, & Immunology, and Frederick Goldman, M.D., Pediatric Hematology & Oncology, will present in a Satellite Conference and Live Webcast Tuesday, August 23 at 2 - 3:30 p.m. The webcast titled "Severe Combined Immunodeficiency: Diagnosis and Treatment" is produced by the Alabama Department of Public Health. Register at: http://www.adph.org/alphtn/. Download the flyer here.
The Medicaid funding situation in Alabama is a critical issue for the state’s health care industry, as well as patients, families and the business community. Alabama health care leaders say securing additional funding is critical for hospitals, physicians and patients from across the state. In this special supplement in the Birmingham Business Journal, three experts, including Mike Warren, CEO of Children's of Alabama and Dr. Will Ferniany,CEO of the UAB Health System, share their thoughts on the funding situation, explain the stakes and show how Medicaid funding impacts not just their facilities, but Alabama’s entire health care system – including patients who are not on Medicaid.
Click here to continue reading.
Click here to continue reading.
Children's patients received a special visit from USA Wheelchair Rugby yesterday afternoon. The team is preparing to leave for the Rio 2016 Paralympic games on Sept. 4. The team spent time with our brave patients and families and gave them a glimpse of what can be possible. Thanks to the Lakeshore Foundation for making this visit possible.
Click here to see the full photo album from yesterday's visit.
Click here to see the full photo album from yesterday's visit.
2016 Nominees from the Department of Pediatrics:
Hussein Abdullatif, M.D., Pediatric Endocrinology, was nominated in the category of Best Educator in Endocrine Systems.
Kimberly Whelan, M.D., Pediatric Hematology & Oncology, was nominated in the category of Best Educator in Hematology & Oncology.
Lauren Nassetta, M.D., and Chang Wu, M.D., of Pediatric Hospital Medicine, were nominated in the category of Best Birmingham Clinical Educator.
The Department of Pediatrics was honored as a nominee for the Best Clinical Department in Birmingham.
The Argus Awards, created in 1996 to recognize faculty members, give medical students the chance to honor their mentors, professors, courses and course directors for outstanding service to medical education. Faculty members are nominated by course evaluations, and students vote to select award winners in each category.
The recipients will be announced and the nominees honored at a ceremony on Friday, October 7. Click here to view the full list of nominees.
Hussein Abdullatif, M.D., Pediatric Endocrinology, was nominated in the category of Best Educator in Endocrine Systems.
Kimberly Whelan, M.D., Pediatric Hematology & Oncology, was nominated in the category of Best Educator in Hematology & Oncology.
Lauren Nassetta, M.D., and Chang Wu, M.D., of Pediatric Hospital Medicine, were nominated in the category of Best Birmingham Clinical Educator.
The Department of Pediatrics was honored as a nominee for the Best Clinical Department in Birmingham.
The Argus Awards, created in 1996 to recognize faculty members, give medical students the chance to honor their mentors, professors, courses and course directors for outstanding service to medical education. Faculty members are nominated by course evaluations, and students vote to select award winners in each category.
The recipients will be announced and the nominees honored at a ceremony on Friday, October 7. Click here to view the full list of nominees.
Leadership in Academic Medicine Lecture will take place at 8 a.m., Tuesday, Aug. 16 in the Margaret Cameron Spain Auditorium. Paul B. Rothman M.D., dean of the medical faculty and vice president for medicine of Johns Hopkins University, and CEO of Johns Hopkins Medicine, will present “Toward a Fully Integrated Academic Health Center.”
The lecture will also be streamed live online. Click here to download the flyer.
The lecture will also be streamed live online. Click here to download the flyer.
Charitharth Vivek Lal, M.D., assistant professor in the UAB Pediatrics Division of Neonatology lead a the study recently published in Scientific Reports. Dr. Lal and other UAB researchers have discovered that an infant's airway — once thought to be sterile until after birth — is colonized by bacteria or bacterial DNA. This could be protective or a predictor for lung disease. To continue reading on UAB News, click here.
Besides Dr. Lal, co-authors of the paper, “The Airway Microbiome at Birth,” from the UAB Department of Pediatrics are Drs. Colm Travers, Tamas Jilling, Brian Halloran, Waldemar A. Carlo, Jordan Keeley, Gabriel Rezonzew and Namasivayam Ambalavanan.
Besides Dr. Lal, co-authors of the paper, “The Airway Microbiome at Birth,” from the UAB Department of Pediatrics are Drs. Colm Travers, Tamas Jilling, Brian Halloran, Waldemar A. Carlo, Jordan Keeley, Gabriel Rezonzew and Namasivayam Ambalavanan.
The American Academy of Pediatrics (AAP) supports the Centers for Disease Control and Prevention’s (CDC’s) interim recommendation that quadrivalent live attenuated influenza vaccine (LAIV4) not be used in any setting during the 2016-’17 season.
Vaccination remains the best preventive measure against influenza, so everyone 6 months and older should receive any age-appropriate trivalent or quadrivalent (no preference) inactivated influenza vaccine (IIV) as soon as available.
Read the AAP cover story written by Henry Bernstein, DO, MHCM, FAAP, and David Kimberlin, M.D., FAAP, on pages 1 and 4 here.
Vaccination remains the best preventive measure against influenza, so everyone 6 months and older should receive any age-appropriate trivalent or quadrivalent (no preference) inactivated influenza vaccine (IIV) as soon as available.
Read the AAP cover story written by Henry Bernstein, DO, MHCM, FAAP, and David Kimberlin, M.D., FAAP, on pages 1 and 4 here.
Inpatient providers can boost protections for children by screening for secondhand tobacco smoke exposure, urging parents who smoke to quit, suggesting smoking cessation interventions and brief counseling sessions to parents interested in behavior change and ensuring the availability of nicotine replacement therapy.
To continue reading the AAP News article written by Karen Wilson, MD, MPH, FAAP, and Susan Walley, M.D., CTTS, FAAP, of the AAP Section on Tobacco Control Executive Committee,click here.
To continue reading the AAP News article written by Karen Wilson, MD, MPH, FAAP, and Susan Walley, M.D., CTTS, FAAP, of the AAP Section on Tobacco Control Executive Committee,click here.
Ride4Gabe is three cyclists, joined by a motorhome, SUV and a documentary film crew, attempting to pedal 200 miles per day from Maine to Mobile to raise awareness and funds for Duchenne Muscular Dystrophy. The ride began on Friday, July 29 and will come through Birmingham this Sunday, August 7, 2016 around 12:30 p.m. Children's of Alabama will hold an event to welcome the riders along with Gabe Griffin. You are invited to attend! There will be shakers and other Children's/UAB staff on hand to welcome the bikers, as well as 20-25 members of a local Bike Club that will ride with them on the leg from Birmingham to Montgomery. Additional details on Ride4Gabe and the fight to end Duchenne Muscular Dystrophy can be found at www.hopeforgabe.org or www.ride4gabe.com.
The inspiration for Ride4Gabe is eleven-year-old Gabe Griffin from Chelsea, Alabama. Gabe has Duchenne, a type of muscular dystrophy caused by the absence of the protein dystrophin. Gabe is the namesake of a tax-exempt non-profit—the Hope for Gabe Foundation—that works nationally to raise Duchenne awareness and research funding. The Alabama Legislature passed “The Gabe Griffin Right to Try Act” after intense lobbying by Gabe and his supporters.
The inspiration for Ride4Gabe is eleven-year-old Gabe Griffin from Chelsea, Alabama. Gabe has Duchenne, a type of muscular dystrophy caused by the absence of the protein dystrophin. Gabe is the namesake of a tax-exempt non-profit—the Hope for Gabe Foundation—that works nationally to raise Duchenne awareness and research funding. The Alabama Legislature passed “The Gabe Griffin Right to Try Act” after intense lobbying by Gabe and his supporters.